{"id":3168,"date":"2023-12-19T07:24:35","date_gmt":"2023-12-19T13:24:35","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=3168"},"modified":"2023-12-19T07:24:35","modified_gmt":"2023-12-19T13:24:35","slug":"fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/","title":{"rendered":"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-3170\" src=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg\" alt=\"pills-6605907_640-e1702315800250\" width=\"533\" height=\"400\" srcset=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg 533w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250-300x225.jpg 300w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250-160x120.jpg 160w\" sizes=\"auto, (max-width: 533px) 100vw, 533px\" \/>The United States Food and Drug Administration (FDA) <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-rare-serious-drug-reaction-antiseizure-medicines-levetiracetam-keppra-keppra-xr-elepsia-xr\" target=\"_blank\" rel=\"noopener\">recently warned<\/a> consumers that certain antiseizure medications can cause a rare but serious response called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). When not diagnosed and treated rapidly, these can prove fatal. The affected seizure medications are levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan). Patients are advised to seek medical attention if they develop swollen lymph nodes, fever, or unexplained rash. If you develop an adverse drug reaction to anti-seizure medications, you should call the seasoned Chicago-based dangerous drug lawyers of Moll Law Group. Billions have been recovered in product liability cases with which we\u2019ve been involved.<\/p>\n<p><strong>Contact Moll Law Group About DRESS<\/strong><\/p>\n<p>The antiseizure medications are approved for different uses. Levetiracetam, which has been FDA-approved for 24 hours and can be accessed in several formulations under the brand names Keppra, Keppra XR, Elepsia XR, and Spritam, and as generics. It can be used along to treat seizures or with other medicines and can be accessed in many formulations under brand names.<\/p>\n<p>Clobazam, for instance, is a benzodiazepine that is FDA-approved for use with other medicines to control linked to a type of epilepsy called Lennox-Gastaut Syndrome. Benzodiazepines depress the central nervous system, but DRESS and other skin reactions are associated with Clobazam, which has been approved by the FDA for 12 years, and not the other benzodiazepines. It can be accessed under the brand names Onfi and Sympazan, and as generics.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#more-3168\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). When not diagnosed and treated rapidly, these can prove fatal. The affected seizure medications are levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-3168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-devices"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 19, 2023<\/title>\n<meta name=\"description\" content=\"The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response &#8212; December 19, 2023\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 19, 2023\" \/>\n<meta name=\"twitter:description\" content=\"The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response &#8212; December 19, 2023\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 19, 2023","description":"The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response &#8212; December 19, 2023","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/","twitter_card":"summary_large_image","twitter_title":"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 19, 2023","twitter_description":"The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response &#8212; December 19, 2023","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/","url":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/","name":"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 19, 2023","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg","datePublished":"2023-12-19T13:24:35+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response &#8212; December 19, 2023","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg","width":533,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-issues-warning-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/12\/pills-6605907_640-e1702315800250.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3168"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3168\/revisions"}],"predecessor-version":[{"id":3171,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3168\/revisions\/3171"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/3170"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}